
Join to View Full Profile
2160 S 1st AveMaywood, IL 60153
Dr. Ahn is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I have been practicing integrative breast oncology now for 18 years (2025) and I have spent half of my career in academics (University of Miami) and half of my career in the for-profit industry (Cancer Treatment Centers of America) where I served as their Enterprise Research Director and helped CTCA become a top enroller for the ASCO TAPUR study, the first basket study run by ASCO utilizing over 18 FDA approved drugs to be used in other cancer types/indications. I am now returned to academics, and serve as an Associate Professor at the Cardinal Bernardin Cancer Center with Loyola University Medical Center. Society for Integrative Oncology (SIO) is my life at times, though I'm taking a break to focus more on academic projects and my new blog - integrativeonc.blog
Education & Training
University of Miami Leonard M. Miller School of MedicineClass of 1997
Certifications & Licensure
IL State Medical License 2023 - 2025
Clinical Trials
- Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer Start of enrollment: 2022 Nov 01
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 Start of enrollment: 2023 Oct 18
Publications & Presentations
PubMed
- 10 citationsPertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer WithAlterations: Results From the Targeted Agent and Profiling Utilization Registry Study.Timothy L Cannon, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vi K Chiu
Journal of Clinical Oncology. 2024-09-20 - 7 citationsTalazoparib in Patients With Solid Tumors With/Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study.Gordan Srkalovic, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn
JCO Precision Oncology. 2024-06-01 - 6 citationsSunitinib in Patients With Breast Cancer WithorAmplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.Carmen J Calfa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn
JCO Precision Oncology. 2024-02-01
Books/Book Chapters
Professional Memberships
- Member
- Society for Integrative Oncology - SIOMember
External Links
- Society for Integrative Oncologyhttp://integrativeonc.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:











